Lupin to pay Rs 1824 crore to settle diabetes drug Glumetza suit in US Medical Dialogues Team23 Sept 2021 3:41 PM ISTNew Delhi: In an out-of-court settlement, Indian generic drug maker Lupin Pharmaceuticals Inc has decided to pay the Direct Purchaser Group Rs 1,103...
Metformin may be potential treatment for pre-eclampsia, finds BMJ study Dr Kartikeya Kohli23 Sept 2021 11:50 AM ISTMetformin may be potential treatment for pre-eclampsia, finds a new study. Metformin administration to women diagnosed with preterm pre-eclampsia may...
Diabetes drug lowers glaucoma risk along with blood sugar control in diabetics: Study Hina Zahid22 Sept 2021 9:15 AM ISTPHILADELPHIA - Glucagon-like peptide-1 receptor (GLP-1R) agonists is a popular class of diabetes medications that regulate blood sugar and are...
GLP1RAs associated with reduced amputation rate and CV risk in diabetics: Study Medha Baranwal15 Sept 2021 9:00 AM ISTTreatment with GLP1RAs, when compared with DPP4is, was associated with significantly lower composite adverse cardiovascular outcomes and major adverse...
Lixisenatide addition to basal insulin helps achieve proper blood sugar control irrespective of BMI Dr Kartikeya Kohli3 Sept 2021 10:45 AM ISTAdd-on lixisenatide can be used to optimize blood sugar control in Asian individuals with type 2 diabetes unable to achieve their HbA1c glycemic...
Canagliflozin reduces risk of hyperkalemia in diabetics with CKD: Study Dr. Shravani Dali28 Aug 2021 9:00 AM ISTThe use of canagliflozin reduces the risk of hyperkalaemia in people with type-2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) without...
Diabetes drug may have role in prevention of glaucoma, finds Study Medha Baranwal27 Aug 2021 5:45 PM ISTUSA: The use of glucagon-like peptide 1 receptor (GLP-1R) agonist significantly lowers hazard reduction for a new diagnosis of glaucoma. The findings,...
Use of DPP-4 inhibitors tied to lower risk of Alzheimer's disease in diabetes patients: Study Hina Zahid13 Aug 2021 10:30 AM ISTResults showed less amyloid in the brains of people taking these medications and less cognitive decline, when compared to people without...
NPPA approves prices of 25 new drugs including Dapagliflozin, Metformin, Details Medical Dialogues Team7 Aug 2021 4:48 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) approved retail pricing for 25 new drugs under the Drug Price Control Order...
Setback to AstraZeneca: Delhi HC rejects plea against 9 pharma firms over Dapagliflozin Medical Dialogues Team26 July 2021 4:12 PM ISTNew Delhi: In a major setback to AstraZeneca and its Indian subsidiary ,the Delhi High Court has dismissed AstraZeneca's plea against nine generic...
AstraZeneca gets US nod for once-weekly diabetes drug Bydureon for kids Ruchika Sharma24 July 2021 4:57 PM ISTThe drug aims to help reduce blood sugar levels along with diet and exercise.
NPPA fixes retail price of 11 formulations, Details Medical Dialogues Team10 July 2021 1:58 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
